News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|July 24, 2024

Multiple Sclerosis: Looking Toward the Future

Author(s)Ryan Haumschild, PharmD, MS, MBA, Heidi Crayton, MD , Maria Lopes, MD, MS

Heidi Crayton, MD, and Maria Lopes, MD, discuss future research in multiple sclerosis that they find exciting and promising.

Episodes in this series

EP. 1 Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

EP. 1 Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis

Video 1 - 3 KOLs are featured in, "Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression"

EP. 2 Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression

Video 2 - 3 KOLs are featured in, "Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis"

EP. 3 Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis

3 KOLs in this program

EP. 4 Examining Key Unmet Needs in Multiple Sclerosis

3 KOLs in this program

EP. 5 Patient Satisfaction: Opportunity for Better Multiple Sclerosis Therapies

A panel of 3 experts on multiple sclerosis

EP. 6 MS Treatment Guidelines: Expert Insights on Updates and Decision-Making

A panel of 3 experts on multiple sclerosis

EP. 7 Incorporating a Subcutaneous Novel Therapy into Multiple Sclerosis Treatment

A panel of 3 experts on multiple sclerosis

EP. 8 Examining Challenges with Drug Switching and Step Therapy in MS Treatment

A panel of 3 experts on multiple sclerosis

EP. 9 Typical Payer Coverage Criteria for Multiple Sclerosis Therapies

A panel of 3 experts on multiple sclerosis

EP. 10 BTK Inhibitors' Rationale and Potential Role in Multiple Sclerosis Treatment

A panel of 3 experts on multiple sclerosis

EP. 11 Updates in Recent Clinical Trials in the Treatment of Multiple Sclerosis

A panel of 3 experts on multiple sclerosis

EP. 12 Primary Progressive Multiple Sclerosis Treatment Landscape: Emerging Therapies

A panel of 3 experts on multiple sclerosis

EP. 13 Multiple Sclerosis: Looking Toward the Future

Video content above is prompted by the following question:

Are there any areas of future research in multiple sclerosis (MS) that you are excited for?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Multiple sclerosis diagnosis: © Vitalii Vodolazskyi - stock.adobe.com.jpg

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

August 7th 2026

Illustration of neurons - Igor - stock.adobe.com.jpg

Epstein-Barr Virus Link to MS Spurs New Vaccine, T-Cell Trials

BySkylar Jeremias

July 27th 2026

Orange multiple sclerosis awareness ribbon cupped in hands | Image credit: SewcreamStudio - stock.adobe.com

MS Diagnostic Delays Persist, Especially in Under-Resourced Areas

July 22nd 2026

stem cell transplant | Image credit: Vadim - stock.adobe.com

Stem Cell Transplant Outperforms DMTs in Drug-Resistant Relapsing MS

BySkylar Jeremias

July 17th 2026

Neurons illustration | Image credit: Anna - stock.adobe.com

MS Likely Unfolds Along a Continuum Years Before First Symptoms

BySkylar Jeremias

July 15th 2026

Trending on AJMC

FDA Approves Novel Iberdomide Regimen in RRMM

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD

AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk

IL-17 Signaling Bridges Psoriasis and Cardiometabolic Risk, Review Finds

Topical Delgocitinib Rivals Dupilumab for Hand Eczema, but Adherence Is Key